Patrick G Enright - Net Worth and Insider Trading

Patrick G Enright Net Worth

The estimated net worth of Patrick G Enright is at least $1.7 Billion dollars as of 2026-09-12. Patrick G Enright is the Director of Corcept Therapeutics Inc and owns about 6,108,328 shares of Corcept Therapeutics Inc (CORT) stock worth over $689 Million. Patrick G Enright is the Director, 10% Owner of Veradermics Inc and owns about 4,653,873 shares of Veradermics Inc (MANE) stock worth over $461 Million. Patrick G Enright is also the Director of Aimmune Therapeutics Inc and owns about 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $213 Million. Besides these, Patrick G Enright also holds Vera Therapeutics Inc (VERA) , Zenas BioPharma Inc (ZBIO) , Bioage Labs Inc (BIOA) , Jazz Pharmaceuticals PLC (JAZZ) , Esperion Therapeutics Inc (ESPR) , Aptinyx Inc (APTX) . Details can be seen in Patrick G Enright's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick G Enright has not made any transactions after 2026-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Patrick G Enright

To

Patrick G Enright Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick G Enright owns 25 companies in total, including Eargo Inc (EAR) , Aimmune Therapeutics Inc (AIMT) , and Aptinyx Inc (APTX) among others .

Click here to see the complete history of Patrick G Enright’s form 4 insider trades.

Insider Ownership Summary of Patrick G Enright

Ticker Company Transaction Date Type of Owner
EAR Eargo Inc 2020-10-15 10 percent owner
AIMT Aimmune Therapeutics Inc 2020-10-10 director
APTX Aptinyx Inc 2020-01-10 director & 10 percent owner
LIMIT LIMIT 2019-11-25 10 percent owner
LIMIT LIMIT 2023-08-14 director & 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2019-11-08 10 percent owner
LIMIT LIMIT 2020-06-11 10 percent owner
LIMIT LIMIT 2019-11-22 10 percent owner
LIMIT LIMIT 2019-11-07 10 percent owner
LIMIT LIMIT 2018-10-30 10 percent owner
LIMIT LIMIT 2018-06-27 10 percent owner
LIMIT LIMIT 2015-05-06 10 percent owner
LIMIT LIMIT 2017-07-19 10 percent owner
LIMIT LIMIT 2017-03-16 director & 10 percent owner
LIMIT LIMIT 2015-03-19 director
LIMIT LIMIT 2007-06-22 director
LIMIT LIMIT 2021-07-19 10 percent owner
LIMIT LIMIT 2021-05-06 10 percent owner
LIMIT LIMIT 2025-12-11 director & 10 percent owner
LIMIT LIMIT 2023-11-02 10 percent owner
LIMIT LIMIT 2025-10-09 director
LIMIT LIMIT 2024-09-25 director
LIMIT LIMIT 2021-05-06 10 percent owner
LIMIT LIMIT 2026-02-03 director & 10 percent owner

Patrick G Enright Latest Holdings Summary

Patrick G Enright currently owns a total of 9 stocks. Among these stocks, Patrick G Enright owns 6,108,328 shares of Corcept Therapeutics Inc (CORT) as of March 16, 2017, with a value of $689 Million and a weighting of 41.59%. Patrick G Enright owns 4,653,873 shares of Veradermics Inc (MANE) as of February 5, 2026, with a value of $461 Million and a weighting of 27.81%. Patrick G Enright also owns 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) as of March 18, 2020, with a value of $213 Million and a weighting of 12.88%. The other 6 stocks Vera Therapeutics Inc (VERA) , Zenas BioPharma Inc (ZBIO) , Bioage Labs Inc (BIOA) , Jazz Pharmaceuticals PLC (JAZZ) , Esperion Therapeutics Inc (ESPR) , Aptinyx Inc (APTX) have a combined weighting of 17.73% among all his current holdings.

Latest Holdings of Patrick G Enright

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2017-03-16 6,108,328 112.79 688,958,315
MANE Veradermics Inc 2026-02-05 4,653,873 98.97 460,593,811
AIMT Aimmune Therapeutics Inc 2020-03-18 6,183,695 34.49 213,275,641
VERA Vera Therapeutics Inc 2025-12-11 5,400,094 35.03 189,165,293
ZBIO Zenas BioPharma Inc 2025-10-09 2,619,189 31.15 81,574,641
BIOA Bioage Labs Inc 2024-09-27 1,710,589 8.47 14,488,689
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 20,946 245.85 5,149,574
ESPR Esperion Therapeutics Inc 2015-03-19 934,396 3.18 2,971,379
APTX Aptinyx Inc 2020-01-10 3,451,746 0.10 331,368

Holding Weightings of Patrick G Enright


Patrick G Enright Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick G Enright has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 269,955 shares on March 16, 2017, which brought Patrick G Enright around $3 Million.

According to the SEC Form 4 filings, Patrick G Enright has made a total of 1 transactions in Veradermics Inc (MANE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Veradermics Inc is the acquisition of 1,075,000 shares on February 5, 2026, which cost Patrick G Enright around $18 Million.

According to the SEC Form 4 filings, Patrick G Enright has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 125,000 shares on March 18, 2020, which cost Patrick G Enright around $1 Million.

More details on Patrick G Enright's insider transactions can be found in the Insider Trading History of Patrick G Enright table.

Insider Trading History of Patrick G Enright

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick G Enright Trading Performance

GuruFocus tracks the stock performance after each of Patrick G Enright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick G Enright is 12.78%. GuruFocus also compares Patrick G Enright's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick G Enright within 3 months outperforms 11 times out of 19 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick G Enright's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick G Enright

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
9 out of 15 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 11.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Patrick G Enright owns.
View CORT Analysis

Patrick G Enright Ownership Network

Ownership Network List of Patrick G Enright

No Data

Ownership Network Relation of Patrick G Enright

Insider Network Chart


Patrick G Enright Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Patrick G Enright is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Patrick G Enright Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick G Enright. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Patrick G Enright's mailing address is: Menlo Park Ca 94025.